APOA1 and metabolic dysfunction-associated steatohepatitis: Indeed, in vitro experiments on hepatocytes showed that overexpression of APOA-I was reported to reduce hepatic endoplasmic reticulum stress and lipogenesis in hepatocytes [253], but a reduction in lipid content was also observed in a NASH mouse model treated with adenoviral vector containing human APOA-I [254,255].